| # | Drug | Count |
|---|---|---|
| 0 | FOSTAMATINIB | 14 |
| 1 | LENALIDOMIDE | 11 |
| 2 | ADALIMUMAB | 9 |
| 3 | ETANERCEPT | 7 |
| 4 | DEXAMETHASONE | 6 |
| 5 | DEXAMETHASONE 1.5 MG | 6 |
| 6 | ASPIRIN | 5 |
| 7 | ASPIRIN 325 MG | 5 |
| 8 | ASPIRIN 81 MG | 5 |
| 9 | AMLODIPINE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OMEPRAZOLE 20 MG | 1 | 0.0049 |
| 1 | FOSTAMATINIB | 14 | 0.0018 |
| 2 | RILONACEPT | 1 | 0.0009 |
| 3 | AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE | 1 | 0.0008 |
| 4 | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0008 |
| 5 | TRASTUZUMAB-ANNS | 1 | 0.0007 |
| 6 | BEVACIZUMAB-AWWB | 3 | 0.0006 |
| 7 | FOSINOPIRL SODIUM | 1 | 0.0005 |
| 8 | TRIPTORELIN PAMOATE | 1 | 0.0004 |
| 9 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 1 | Antimalarial [EPC] | 1 | 0.0001 |
| 2 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 3 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 4 | Soluble Guanylate Cyclase Stimulator [EPC] | 3 | 0.0001 |
| 5 | Radioligand Therapeutic Agent [EPC] | 1 | 0.0001 |
| 6 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1 | 0.0001 |
| 7 | Thiazide-like Diuretic [EPC] | 2 | 0.0000 |
| 8 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 9 | Bile Acid [EPC] | 1 | 0.0000 |